A potential role for insulin resistance in experimental pulmonary hypertension
about
The Role of Hyperglycemia and Insulin Resistance in the Development and Progression of Pulmonary Arterial HypertensionChallenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the LungsBMPR2 spruces up the endothelium in pulmonary hypertensionTargeting the Wnt signaling pathways in pulmonary arterial hypertensionThe genetics of pulmonary arterial hypertensionDysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertensionImpact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension.Interaction between bone morphogenetic protein receptor type 2 and estrogenic compounds in pulmonary arterial hypertensionInsulin resistance in pulmonary arterial hypertension, is it a novel disease modifier?Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension.Rescuing the BMPR2 signaling axis in pulmonary arterial hypertensionThe Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension.Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular MetabolismHypothesis: neuroendocrine mechanisms (hypothalamus-growth hormone-STAT5 axis) contribute to sex bias in pulmonary hypertension.Metabolic Dysfunction in Pulmonary Arterial Hypertension.Bone Marrow-derived Cells Contribute to the Pathogenesis of Pulmonary Arterial Hypertension.The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice.Antagonism of the thromboxane-prostanoid receptor is cardioprotective against right ventricular pressure overload.Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension.Inhibition of fatty acid synthase is protective in pulmonary hypertension.Gender, sex hormones and pulmonary hypertension.Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension.Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension.Update in pulmonary vascular diseases 2012.Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy.Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis.Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle.Echocardiographic assessment of the right heart in mice.Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension.Echocardiographic Pulmonary Artery Systolic Pressure in the Coronary Artery Risk Development in Young Adults (CARDIA) Study: Associations With Race and Metabolic Dysregulation.Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertensionRole of cardiac inflammation in right ventricular failure.Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension.Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension.Abnormal Glucose Metabolism and High-Energy Expenditure in Idiopathic Pulmonary Arterial Hypertension.Metabolic Status in Patients with Operable vs. Inoperable Left-to-Right Shunts.Transcriptional regulation of metabolism in disease: From transcription factors to epigenetics.Clinical and genetic associations with prostacyclin response in pulmonary arterial hypertension
P2860
Q26744761-B4C43258-E6E2-4C91-83C0-3F3CFF7A7214Q26766294-6BE032F8-9DB6-4DCD-8097-EEC75026C6A8Q26786834-31134862-AD40-45E1-BF3D-DE90E0C8AAC3Q27006826-4BD1F622-F71B-4183-AE16-355B0F82860AQ27027507-2197DCE9-3580-4404-857D-A8E620FFD8AEQ33738642-679098F8-9C5B-4D25-819D-32A495C955E6Q33806024-267759E3-356F-4451-999A-927E7FA46E25Q33806083-4C1D154B-C6DE-4FAE-832B-7C353E579A87Q34621276-890C55A3-46BA-49D9-AA3B-8B10B5C9C9CCQ35019516-FB4272C6-A5AA-4D86-B705-849361210C41Q35410950-98184B44-286B-4EAC-9147-41D32ABC6CBBQ35975165-EB76D250-9CEA-429F-8A7A-31AF785FBCB9Q36421287-4288FCE2-E21C-4BB9-9AD5-5FEC0538574FQ36568290-3F60082C-FAC6-450F-999D-628C2DC74452Q36825335-3E6E3101-DCD9-461E-B5C7-14062204CCA4Q36847595-E1DF0FE2-5AB7-499A-9207-11845BEADC93Q36878827-1043DC4D-3410-4D8F-8CA5-C05A8E221567Q36908852-0E9341D1-77BC-40E6-8466-CC17A4BD6F77Q36909329-980A7DBF-BAEB-47C0-ACAE-493BCCE4EF01Q36941262-334E900C-44BC-43CE-B010-658ADBEAEDD8Q37133789-8C24706C-CE36-49F7-ABB4-533F9611C454Q37596437-3D9AEB34-9926-4CA2-8010-B96EBB9177CDQ37688533-8020984E-4442-4ED9-9DCC-102A72C9CDACQ38118390-33F4E2BD-8910-47F1-B9F6-79526D472CFBQ38524717-A973DB6B-F5DE-4F50-BE13-CE26BD597C96Q38642429-E922B2ED-29BC-4826-80A8-BDB41F620D67Q38669078-526FC41B-66CC-40F0-9CFA-9BDE26EF4D0BQ38778327-B6ED9B1A-189F-450D-A9B6-EB64E007B6B9Q38833632-BC5EE809-BA97-492D-8670-58C4181A5331Q39118942-0A5D28CB-7631-41AD-B5A5-FEDC9B8BDA4EQ41166063-F9EB859A-AF02-4D02-8716-400278C84899Q41922644-05E03097-5F1B-46C7-98FA-FD49D8E592C3Q45068688-FF3C1D8C-BC04-44C4-86BE-61F357795ABBQ46336560-8F1E1EE9-BBE4-4953-B028-66341CB7785EQ47233697-19D63A8E-699B-450E-9346-9D8284C02DC3Q48025977-624EA348-DF15-4A78-B07C-893617F0D5B2Q53690478-E84F770E-3CBC-4C6E-9E8A-9AE7DB9DB9CFQ55260615-A00847E9-630D-44B3-971F-4DB7A10FCDF1Q58704706-92F58F1B-A050-44A9-856A-585C71614297
P2860
A potential role for insulin resistance in experimental pulmonary hypertension
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 August 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A potential role for insulin resistance in experimental pulmonary hypertension
@en
A potential role for insulin resistance in experimental pulmonary hypertension.
@nl
type
label
A potential role for insulin resistance in experimental pulmonary hypertension
@en
A potential role for insulin resistance in experimental pulmonary hypertension.
@nl
prefLabel
A potential role for insulin resistance in experimental pulmonary hypertension
@en
A potential role for insulin resistance in experimental pulmonary hypertension.
@nl
P2093
P2860
P1476
A potential role for insulin resistance in experimental pulmonary hypertension
@en
P2093
Anna R Hemnes
Jennifer A Johnson
Joshua P Fessel
Kevin D Niswender
Linda Gleaves
Meredith E Pugh
P2860
P304
P356
10.1183/09031936.00030312
P577
2012-08-30T00:00:00Z